- Home
- WHLR vs MBIO Comparison
WHLR vs MBIO Comparison
Compare WHLR & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- MBIO
- Stock Information
- Founded
- WHLR 2011
- MBIO 2015
- Country
- WHLR United States
- MBIO United States
- Employees
- WHLR N/A
- MBIO N/A
- Industry
- WHLR Real Estate Investment Trusts
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- MBIO Health Care
- Exchange
- WHLR Nasdaq
- MBIO Nasdaq
- Market Cap
- WHLR 4.2M
- MBIO 4.7M
- IPO Year
- WHLR 2012
- MBIO N/A
- Fundamental
- Price
- WHLR $2.30
- MBIO $1.58
- Analyst Decision
- WHLR
- MBIO
- Analyst Count
- WHLR 0
- MBIO 0
- Target Price
- WHLR N/A
- MBIO N/A
- AVG Volume (30 Days)
- WHLR 4.5M
- MBIO 114.6K
- Earning Date
- WHLR 11-06-2025
- MBIO 11-07-2025
- Dividend Yield
- WHLR N/A
- MBIO N/A
- EPS Growth
- WHLR N/A
- MBIO N/A
- EPS
- WHLR N/A
- MBIO N/A
- Revenue
- WHLR $102,799,000.00
- MBIO N/A
- Revenue This Year
- WHLR N/A
- MBIO N/A
- Revenue Next Year
- WHLR N/A
- MBIO N/A
- P/E Ratio
- WHLR N/A
- MBIO N/A
- Revenue Growth
- WHLR N/A
- MBIO N/A
- 52 Week Low
- WHLR $1.50
- MBIO $0.89
- 52 Week High
- WHLR $8,593.20
- MBIO $21.95
- Technical
- Relative Strength Index (RSI)
- WHLR 51.46
- MBIO 50.09
- Support Level
- WHLR N/A
- MBIO $1.54
- Resistance Level
- WHLR $2.59
- MBIO $1.64
- Average True Range (ATR)
- WHLR 0.29
- MBIO 0.08
- MACD
- WHLR 0.08
- MBIO 0.02
- Stochastic Oscillator
- WHLR 88.80
- MBIO 81.82
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.